Skip to main content

Table 2 The proportion of patients based on P/F ratio within fecal calprotectin groups

From: Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients

P/F Ratio (mmHg)

Total

(n = 44)

FC-negative (< 50)

(n = 26)

FC-positive (≥ 50)

(n = 18)

Mean ± SD

312.18 ± 137.78

396.19 ± 100.45

190.83 ± 82.41

P/F Ratio ≤ 100 (Severe ARDS)

2 (4.54%)

0 (0%)

2 (11.11)

100 < P/F Ratio ≤ 200 (Moderate ARDS)

10 (22.72%)

1 (3.85%)

9 (50%)

200 < P/F Ratio ≤ 300 (Mild ARDS)

10 (22.72%)

4 (15.39%)

6 (33.33%)

P/F Ratio > 300 (Non-ARDS)

22 (50%)

21 (80.77%)

1 (5.56%)

  1. *Data are presented as numbers (percentages) and mean ± SD. P/F, PaO2/ FiO2; ARDS acute respiratory distress syndrome, FC fecal calprotectin